SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

81,028.02 1,718.01
( 2.17%)

Global Indices

Nasdaq

51,462.04 -82.02
(-0.16%)

Dow Jones

7,424.83 50.10
(0.68%)

Hang Seng

57,293.47 -3,784.43
(-6.20%)

Nikkei 225

10,662.59 -120.07
(-1.11%)

Forex

USD-INR

94.41 -0.18
(-0.19%)

EUR-INR

106.07 -0.23
(-0.22%)

GBP-INR

127.18 -0.23
(-0.18%)

JPY-INR

0.60 0.00
(-0.04%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Divis Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

532488

INE361B01024

629.4942217

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DIVISLAB

91.32

273565.37

EPS(TTM)

Face Value()

Div & Yield %

112.85

0.29

Back

Aditya Birla Real Estate reports consolidated net loss of Rs 38.55 crore in the June 2026 quarter

Aug 13,2026

Net Loss of Aditya Birla Real Estate reported to Rs 38.55 crore in the quarter ended June 2026 as against net loss of Rs 25.47 crore during the previous quarter ended June 2025. Sales rose 30.40% to Rs 188.05 crore in the quarter ended June 2026 as against Rs 144.21 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	188.05	144.21	30
OPM %	-30.15	-29.39	-
PBDT	-65.65	-37.60	-75
PBT	-83.00	-53.10	-56
NP	-38.55	-25.47	-51

81,028.02 1,718.01 ( 2.17%)

51,462.04 -82.02 (-0.16%)

7,424.83 50.10 (0.68%)

57,293.47 -3,784.43 (-6.20%)

10,662.59 -120.07 (-1.11%)

94.41 -0.18 (-0.19%)

106.07 -0.23 (-0.22%)

127.18 -0.23 (-0.18%)

0.60 0.00 (-0.04%)